You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. High Speed High Accuracy Artificial Neural Networks for UAV based Target Identification

    SBC: UHV TECHNOLOGIES, INC.            Topic: AF18BT007

    The machine learning and artificial intelligence community has recently garnered much attention for ground breaking performance of novel neural network architectures for self-driving cars. One of the machine learning methods used in self-driving cars is semantic segmentation. In this fashion each pixel in an image is label with a class, allowing for contour-based image segmentation which is differ ...

    STTR Phase I 2019 Department of DefenseAir Force
  2. Provably Unclonable Functions on Re-configurable Devices

    SBC: IERUS TECHNOLOGIES INC            Topic: A18BT001

    The ability to authenticate electronic devices is an important step towards modernizing the hardware/software of our Nations communication systems. Protecting these targeted networks and devices from malicious cyber-based attacks is becoming increasingly important as the technological and cyber capabilities of our adversaries continue to advance. In addition to network security, device authenticat ...

    STTR Phase I 2018 Department of DefenseArmy
  3. Electronically Dimmable Eye Protection Devices (EDEPD)

    SBC: Aegis Technologies Group, LLC, The            Topic: AF18BT003

    Electronically dimmable materials with sufficiently strong visible transmission shift, color neutrality, durability and switching speeds have eluded development since the search began nearly half a century ago. We demonstrate the potential for dynamic optical dimming using plasmonic nanostructures with electrodynamic simulations of promising plasmonic metamaterial architectures. In order to achiev ...

    STTR Phase I 2019 Department of DefenseAir Force
  4. Regional Radio Frequency Attenuation and Interference Monitor (RF-AIM)

    SBC: Silvus Technologies, Inc.            Topic: AF18BT005

    Silvus Technologies and the University of California Los Angeles propose a system design and a rapid development path for the Regional Radio Frequency Attenuation and Interference Monitor, or ‘RF-AIM’. RF-AIM is intended to provide continuous wide area awareness of RF spectrum availability in the presence of arbitrary interference and attenuation from natural or man-made causes. The t ...

    STTR Phase I 2019 Department of DefenseAir Force
  5. Carbon Nanotube FET Modeling and RF circuits

    SBC: CARBON TECHNOLOGY INC            Topic: AF18BT006

    The proposed work aims at detailed investigation of Carbon Nanotube Field-Effect Transistor (CNTFET) device design and its impact on Radio-frequency (RF) circuit performance in comparison to Si-MOSFETs and related circuits at the same channel lengths. The goal is to establish a geometry scalable CNTFET compact model for RF circuit design and determine its parameters based on characteristics from b ...

    STTR Phase I 2019 Department of DefenseAir Force
  6. An Integrated Materials Informatics/Sequential Learning Framework to Predict the Effects of Defects in Metals Additive Manufacturing

    SBC: Citrine Informatics, Inc.            Topic: N18AT013

    In this project, Citrine Informatics and the ADAPT Center at the Colorado School of Mines propose to build an informatics-driven system to understand the effects of defects in additive manufactured parts. The entire history of each sample will be captured on this system; from specific printing parameters and details of precursor materials through to part characterizations and performance measureme ...

    STTR Phase I 2018 Department of DefenseNavy
  7. Circulating Diagnostic Markers of Infectious Disease

    SBC: PATHOVACS INCORPORATED            Topic: CBD18A001

    The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  8. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  9. Analysis and Application of Treatments to Mitigate Exfoliation Corrosion (Delamination) of 5XXX Series Aluminum

    SBC: OCEANIT LABORATORIES INC            Topic: N18AT016

    Oceanit proposes to research and develop chemical or non-chemical methods and processes to impart surface morphology modifications to aluminum-magnesium (Al-Mg) alloys to mitigate and increase the exfoliation corrosion resistance.

    STTR Phase I 2018 Department of DefenseNavy
  10. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government